IRIS
BELLODI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.836
EU - Europa 4.104
NA - Nord America 3.089
SA - Sud America 1.208
AF - Africa 66
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 13.314
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.943
RU - Federazione Russa 2.601
SG - Singapore 1.740
CN - Cina 1.646
BR - Brasile 995
SE - Svezia 696
HK - Hong Kong 604
VN - Vietnam 437
FR - Francia 253
IT - Italia 136
DE - Germania 103
AR - Argentina 89
GB - Regno Unito 81
IN - India 74
BD - Bangladesh 72
IE - Irlanda 72
CA - Canada 66
EC - Ecuador 40
FI - Finlandia 38
ID - Indonesia 38
MX - Messico 38
TR - Turchia 35
IQ - Iraq 34
JP - Giappone 31
CO - Colombia 28
ZA - Sudafrica 26
PK - Pakistan 23
PL - Polonia 23
AT - Austria 21
ES - Italia 17
PY - Paraguay 16
UA - Ucraina 15
UZ - Uzbekistan 14
VE - Venezuela 14
AE - Emirati Arabi Uniti 12
UY - Uruguay 12
CL - Cile 11
SA - Arabia Saudita 11
IR - Iran 9
MA - Marocco 9
JM - Giamaica 8
NL - Olanda 8
DZ - Algeria 7
NP - Nepal 7
PH - Filippine 7
DO - Repubblica Dominicana 6
EG - Egitto 6
HN - Honduras 6
MD - Moldavia 6
BY - Bielorussia 5
GR - Grecia 5
LT - Lituania 5
TT - Trinidad e Tobago 5
XK - ???statistics.table.value.countryCode.XK??? 5
KE - Kenya 4
KR - Corea 4
LB - Libano 4
RS - Serbia 4
TN - Tunisia 4
AU - Australia 3
BB - Barbados 3
BN - Brunei Darussalam 3
CR - Costa Rica 3
DK - Danimarca 3
GT - Guatemala 3
JO - Giordania 3
KG - Kirghizistan 3
KZ - Kazakistan 3
OM - Oman 3
SV - El Salvador 3
AZ - Azerbaigian 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
ET - Etiopia 2
HR - Croazia 2
IL - Israele 2
KH - Cambogia 2
KW - Kuwait 2
MY - Malesia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PE - Perù 2
PS - Palestinian Territory 2
RO - Romania 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
GY - Guiana 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MR - Mauritania 1
MU - Mauritius 1
PA - Panama 1
Totale 13.307
Salva come PNG Salva come JPEG
Città #
Singapore 679
Hong Kong 600
Moscow 584
Dallas 565
San Jose 469
Ashburn 413
Shanghai 306
Hefei 252
Lawrence 252
Princeton 249
Lauterbourg 211
Ho Chi Minh City 159
New York 108
Beijing 97
Hanoi 87
São Paulo 81
Dublin 72
Los Angeles 70
Santa Clara 49
Orem 34
The Dalles 32
Brasília 30
Helsinki 30
Milan 27
Rio de Janeiro 27
Belo Horizonte 26
Brooklyn 26
Washington 26
Boardman 25
Pune 23
Guangzhou 22
Haiphong 22
Montreal 21
Guayaquil 20
Warsaw 20
Columbus 19
London 19
Nuremberg 19
Da Nang 17
Tokyo 17
Chennai 16
Biên Hòa 15
Curitiba 15
Houston 15
Atlanta 14
Denver 14
Boston 13
Buenos Aires 13
Mexico City 13
Stockholm 13
Porto Alegre 12
Toronto 12
Changsha 11
Chicago 11
Johannesburg 11
Manchester 11
Salvador 11
Shenzhen 11
Suita 11
Tashkent 11
Ankara 10
Baghdad 10
Guarulhos 10
Hải Dương 10
Phoenix 10
San Francisco 10
Seattle 10
Sorocaba 10
Tianjin 10
Frankfurt am Main 9
Gainesville 9
Karachi 9
Rome 9
Campinas 8
Jakarta 8
Montevideo 8
Ninh Bình 8
Paris 8
Quito 8
Vienna 8
Asunción 7
Manaus 7
Medellín 7
Recife 7
Thái Bình 7
Bogotá 6
Canoas 6
Delhi 6
Dhaka 6
Hortolândia 6
Joinville 6
Kassel 6
Limeira 6
New Delhi 6
Poplar 6
São Bernardo do Campo 6
São Leopoldo 6
Turku 6
Uberlândia 6
Aracaju 5
Totale 6.364
Salva come PNG Salva come JPEG
Nome #
[F-18] FDG PET study in obsessive-compulsive disorder. A clinical metabolic correlation study after treatment 149
A psychometric-genetic study of schizotypal disorder 135
A FAMILY STUDY OF SCHIZOTYPAL DISORDER 125
5HT2C CYS23/SER23 polymorphism is not associated with obsessive-compulsive disorder 117
Abnormal pattern of cortical activation associated with voluntary movement in obsessive-compulsive disorder: An EEG study 114
5% CO2 challenge in healthy first degree relatives of patients with panic disorder 109
AGE AT ONSET OF PANIC DISORDER - INFLUENCE OF FAMILIAL LIABILITY TO THE DISEASE AND OF CHILDHOOD SEPARATION ANXIETY DISORDER 108
35% CO2-65% O2 inhalation test in panic patients 106
A long-term prospective evaluation of first-degree relatives of panic patients who underwent the 35% CO2 challenge 106
A psychosocial risk factor model for female eating disorders: A European multicentre project 102
A comparison of citalopram and paroxetine in the treatment of panic disorder: A randomized, single-blind study 100
Age at onset of panic disorder: influence of familial liability to the disease and of childhood separation anxiety disorder. American Journal of Psychiatry, 152: 1362-1364, 1995 99
A neural network approach to the outcome definition on first treatment with sertraline in a psychiatric population 98
Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis 97
A new social-family model for eating disorders: A European multicentre project using a case–control design 96
A combined population and family-based study of eight European populations demonstrates association between BDNF and eating disorders. 96
A neuropsychological study of dissociation in cortical and subcortical functioning in Obsessive-Compulsive Disorder by Tower of Hanoi Task 95
Acoustic startle response in panic disorder 94
A segregation study for panic disorder families in which probands are responsive to 35% CO2 challenge test. 93
Alpha reactivity in schizophrenia and in schizophrenic spectrum disorders: demographic, clinical and hemispheric assessment. 91
Assessment of parent-of-origin effect in families unlineally affected with panic disorder-agoraphobia 90
Health-related quality of life in euthymic bipolar disorder patients: Differences between bipolar I and II subtypes 81
Visuo-tactile shape perception in women with Anorexia Nervosa and healthy women with and without body concerns 81
A segregation study of panic disorder in families of panic patients responsive to the 35% CO2 challenge 79
Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: A single-blind study 78
Emotional Intelligence in Panic Disorder 76
Obsessive compulsive disorder and mood disorders: A family study 76
Assessment of parent-of-origin effect in families unilineally affected with Panic Disorder Agoraphobia. Journal of Psychiatric Research, 33: 37-39, 1999 75
An assessment of the Wisconsin Card Sorting Test as an indicator of liability to schizophrenia. 71
Cross-disorder genome-wide analyses suggest a complex genetic relationship between tourette's syndrome and OCD 70
Clinical predictors of drug response in obsessive-compulsive disorder 67
Morbidity Risk For Mood Disorders In The Families Of Borderline Patients 66
The Iowa Personality Disorder Screen: Development and preliminary validation of a brief screening interview 66
Dizziness, migrainous vertigo and psychiatric disorders 65
Anticipation of age at onset in panic disorder 65
Perceived vs. desired body size estimations in samples of anorectic and bulimic patients - MANUSCRIPT IN PREPARATION 65
Panic disorder: the role of the balance system 64
Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder: a controlled, double dissociation study 64
Temperament dimensions explain comorbidity of psychiatric disorders. Comprehensive Psychiatry, 37 (4): 292-298, 1996 63
Carbon Dioxide/Oxygen Challenge Test in Panic Disorder. 63
The structure of DSM-III-R schizotypal personality disorder diagnosed by direct interviews 63
Familial risks and reproductive fitness in schizophrenia 62
The Co-Occurrence of DSM III-R Personality Disorders. 62
An assessment of the Wisconsin Card Sorting Test as an indicator of liability to Schizophrenia. Schizophrenia Research, 14: 39-46, 1994 62
Family history of panic disorder and hypersensitivity to CO2 in patients with panic disorder 61
Psychiatric disorders in the families of schizotypal subjects. Schizophrenia Bulletin,17 (4): 659-668, 1991 60
Anticipation of age at onset in Panic Disorder. American Journal of Psychiatry,155 (5):590-595, 1998 60
CARDIAC AUTONOMIC FUNCTION DURING SLEEP OF NEVER-DEPRESSED BORDERLINE SUBJECTS - A PILOT-STUDY 60
Simultaneous determination of clomipramine and its desmethyl and hydroxy metabolites in plasma of patients by high-performance liquid chromatography after solid-phase extraction 60
Decision-making heterogeneity in obsessive-compulsive disorder: Ventromedial prefrontal cortex function predicts different treatment outcomes 59
Complex segregation analysis for obsessive compulsive disorder and related disorders 59
Further studies on the major histocompatibility complex as a genetic marker for schizophrenia. 59
Psychophysiological patterns of children at risk for panic disorder 59
Ambulatory polysomnography of never-depressed borderline subjects: a high-risk approach to rapid eye movement latency. 59
Fat mass and obesity-associated gene (FTO) in eating disorders: evidence for association of the rs9939609 obesity risk allele with bulimia nervosa and anorexia nervosa 59
EEG power modifications in obsessive-compulsive disorder during olfactory stimulation 58
Histocompatibility antigens and effects of neuroactive drugs on phytohaemagglutinin stimulation of lymphocytes in vitro. 58
Schizotypy in Partners of Patients with Schizotypal Personality Disorder 58
The unipolar-bipolar dichotomy and the response to sleep deprivation 58
Functional promoter polymorphism of the human serotonin transporter: Lack of association with panic disorder 58
Personality Features Related to Generalized Anxiety Disorder. 57
First-cycle REM density in never-depressed subjects with Borderline personality disorder. Biological Psychiatry 45: 1056-1058, 1999 57
Low social interactions in eating disorder patients in childhood and adulthood: a multi-centre European case control study. 57
Psychoimmunoendocrine aspects of panic disorder. 56
Serotonergic modulation of the balance system in panic disorder: An open study 56
HYPERSENSITIVITY TO INHALATION OF CARBON-DIOXIDE AND PANIC ATTACKS 56
Morbidity risk for obsessive-compulsive spectrum disorders in first-degree relatives of patients with eating disorders 56
Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response. 56
Fluvoxamine treatment and D-2 receptors: a pet study on OCD drug-naive patients 55
Common genetic, clinical; demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders 55
Proclactin secretion and response to stimuli in male heroin addicts. 55
Temperament dimensions explain the comorbidity of psychiatric disorders 55
Evaluation of mother-child agreement and factorial structures of the SCARED questionnaire in an Italian clinical sample 55
Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study 54
Cardiac autonomic function during sleep of never-depressed Borderline subjects: a pilot study. Journal of Psychiatric Research, 29: 397-405, 1995 54
Subclinical Impairment of Lung Airways in Patients with Panic Disorder. 54
Promoter polymorphisms of the 5HT2C receptor gene: Association study with panic disorder in two independent samples. 54
COMORBIDITY OF PANIC AND SOMATIZATION DISORDER - A GENETIC-EPIDEMIOLOGIC APPROACH 54
Family study of schizophrenia: exploratory analysis for relevant factors. 54
Citalopram and panic disorder. 54
Genetic variants of dopamine receptor D4 and psychopathology 54
Comorbidity of Panic and Somatization disorder: a genetic epidemiological approach. Comprehensive Psychiatry, 36 (6): 411-420, 1995 54
Possible linkage between primary affective disorder susceptibility locus and HLA haplotypes. 54
Sensitivity to 35% carbon dioxide in patients with generalized anxiety disorder 54
Executive Dysfunctions in Obsessive-Compulsive Patients and Unaffected Relatives: Searching for a New Intermediate Phenotype 53
DSM III-R Personality Disorders in Panic Disorder. 53
Polymorphic MAO-A and 5-HT-transporter genes: analysis of interactions in panic disorder. 53
Analytic considerations about distribution of age of onset in schizophrenia. 53
CO2-induced panic attacks: A twin study 52
The effect of one-week treatment with venlafaxine on 35% CO2 hyperreactivity in patients with panic disorder: An open study 52
Further study on N1-methylnicotinamide urinary output in patients with affective disorders. 52
Growth hormone response to growth hormone-releasing hormone stimulation in obsessive-compulsive disorder 52
LABORATORY RESPONSE OF PATIENTS WITH PANIC AND OBSESSIVE-COMPULSIVE DISORDERS TO 35-PERCENT CO2 CHALLENGES 52
The structure of DSM-III-R schizotypal personality disorder diagnosed by direct interviews. Schizophrenia Bulletin, 23 (1) 83-92, 1997 51
Novel Antidepressants and Panic Disorder: Evidence beyond Current Guidelines 51
In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder 51
No association between eating disorders, obsessive-compulsive disorder and 1438G/A 5-HT2A promoter polymorphism in an Italian population. 51
Genetic modelling in schizophrenia according to HLA typing. 51
Paroxetine and respiration in panic disorder: preliminary results 51
Bulimia nervosa, 5-HTTLPR polymorphism and treatment response to four SSRIs: a single-blind study 51
Totale 6.898
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.561
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202293 0 0 0 39 9 5 4 6 3 8 2 17
2022/20231.289 528 313 98 8 4 128 79 80 37 3 3 8
2023/2024454 10 8 38 52 30 128 15 35 5 14 15 104
2024/20252.631 379 62 24 62 46 232 278 183 558 436 201 170
2025/20268.846 606 684 777 1.382 460 272 865 614 2.441 471 140 134
Totale 13.338